Skip to main content
. 2022 Feb;51(2):306–317. doi: 10.18502/ijph.v51i2.8683

Table 1:

Risk factors associated with lung cancer in Iran

Author publication Year Location Sample size Related factor Risk index
Nadji SA. (58) 2007 Mazandaran Case:141
control: 92
active smoking, HPV infection NA
Hosseini-Khalili A. (53) 2009 Tehran 20 male mustard gas NA
Hosseini M. (45) 2009 Tehran Case:242
Control: 242
Smoking OR(CI): 5.4(3.2–8.9)
Occupational exposures to inorganic dusts OR(CI): 4.2(2.8–6.7)
chemical compounds OR(CI): 3.4 (2.1–5.6)
heavy metals OR(CI): 3.0(1.3–7.0)
Razmkhah m. (59) 2005 Shiraz Case: 72
Control: 262
AG genotypes of SDF-1 p-value =0.008
Mosavi-Jarr Ahi A (60) 2009 Iran 12,488,020 men, 677,469 women occupational exposure RR(CI):1.9 (1.7–2.1) for high exposure 1.3 (1.2–1.4)for low exposure
Karimzadeh L. (61 2011 Tehran Case: 40
Control: 40
consumption of baked bread in traditional oven OR(CI): 22.6(1.9–270)
Mahaki B. (62) 2011 Iran - Smoking Posterior Median : 1.067
Karimzadeh L. (56) 2012 Tehran Case: 50
Control: 50
nitrate and nitrite OR(CI): 2.7( 0.13–0.96)
Masjedi MR. (49) 2013 Tehran case: 242 Control: 484 Smoking OR(CI): 6.2 (3.3–11.6)
Male/Female OR(CI): 3.1 (1.2–8.1)
Hosseini M. (47) 2014 Tehran case: 242 Control: 484 Bread OR(CI): 1.54 (1.02–2.32)
Rice OR(CI): 1.84(1.17–2.89)
beef (Upper third month) OR(CI): 2.67 (1.39–5.10)
Butter Middle third month OR(CI): 1.70(1.07–2.71)
Upper third month OR(CI): 2.94 (1.79–4.82)
White cheese Middle third month OR(CI): 3.87 (2.52–2.93)
Upper third month OR(CI): 6.52 (3.49–12.18)
Yogurt Middle third month OR(CI): 2.37 (1.46–3.83)
Upper third month OR(CI): 2.98 (1.77–5.00)
vegetable ghee OR(CI): 2.27 (1.17–4.40)
animal ghee OR(CI): 7.71 (3.17–18.74)
Najafi F. (48) 2016 Iran 413591 -daily cigarette smoking
-low consumption of vegetables
NA
Safari A. (63) 2016 Tehran 490 Opium consumption NA
Dehghani M. (64) 2018 Yasuj Case:34
Control: 61
C allele
rs2645429 in Farnesyl-Diphosphate Farnesyltransferase 1
OR(CI):
C allele 2.71(1.12–6.59)
CC : 3.02(1.09–8.39)
Motovali-Bashi M. (65) 2012 Isfahan Case: 65
Control: 80
possessed heterozygous (*1/*2A) genotype OR(CI): 2.79(1.01–7.65).
Zafarghandi MR. (51) 2013 Iranian veterans 7,570exposed and 7,595 unexposed with 25-year follow-up Sulfur mustard exposure Incidence rate ratio: 1.81 (95 % CI 1.27–2.56), Age adjusted incidence rate ratio 1.64 (95 % CI 1.15–2.34), HR of cancer: 2.02 (95 % CI 1.41–2.88).
Keeley BR. (66) 2014 Golestan Case: 78
Control: 81
G-CSF OR: 27.7
GM-CSF OR: 13.3
Nikseresht M. (67) 2018 Yasuj Case: 34
Control: 50
C-allele of the rs2245214 ATG5 gene polymorphism OR(CI): 3.52(1.33-9.26)
Adibhesami G. (68) 2018 Tehran Case: 120
Control: 120
T0M1 / T1M1 genotype was OR(CI): 3.46(1.61–7.46)
Rahmati A. (69) 2016 Golestan 50,045 adults enrolled from 2004 to 2008, followed annually until June 2015 Opium use HRs (1.73 (95% CI: 0.99–3.03)
Eydian Z. (70) 2016 Zabol Case: 200
Control: 200
P53 codon 72 polymorphism Non-significant
Motovali-Bashi M. (71) 2014 Isfahan Case: 288
Control: 352
Lys751Gln polymorphism OR(CI):1.8(I 0.848–3.819)
751Gln/Gln genotype OR(CI): 0.7(0.307–1.595).
Karimzadeh L. (56) 2012 Tehran Case: 40
Control: 40
Animal sources of nitrate and nitrite intake OR(CI): 2.7(0.13–0.9)
fruit intake OR(CI): 0.26 (1.3–11)
Rikhtegar S. (72) 2018 Tehran Case: 50
Control: 50
KRAS P-value :0.01
NRAS expression levels P-value :0.001
Ahmadi M. ( 73 ) 2018 Yazd Case: 96
Control: 100
CHRNA3 rs1051730 single nucleotide polymorphism Non-significant
Chitsaz M. ( 74 ) 2018 Tehran Case: 50
Control: 50
Expression of EGFR And FGFR4 Genes P-value :0.003
Amini F. (75) 2017 Isfahan Case: 61
Control: 111
miR-214-binding site polymorphism in EGFR Non-significant
Motovali-Bashi M. ( 76 ) 2012 Isfahan Case: 120
Control: 100
Distribution of C(−1562)T genotype in type IV collagenase promoter OR(CI): 19.89 (3.21–120.60) in age group of < 60 yr
Motovali-Bashi M. ( 35 ) 2012 Isfahan Case: 172
Control: 123
gelatinase B genotype OR(CI): 2.56(0.06–23.82)
Motovali-Bashi M. ( 77 ) 2012 Isfahan Case: 112
Control: 120
T/C single nucleotide polymorphism in CYP1A1 gene P-value :0.001
C allele P-value : 0.0001
Motovali-Bashi M. ( 78 ) 2013 Isfahan Case: 120
Control: 110
−765G/C polymorphism of cyclooxygenase 2 genes P-value : 0.06
Rashidi M. (55) 2014 Isfahan - Arsenic -
Mobasheri MR. ( 58 ) 2014 - - particulate matter <2.5 micrometers R=0.65
Ghayyoumi M. ( 79 ) 2015 Shiraz Case: 50
Control: 38
Serum level of Triose Phosphate Isomerase P-value: 0.76
Hamedi F. ( 80 ) 2017 Fars Case: 100
Control: 100
Gln/Gln in male. P-value: 0,044
Keshvary Ravan H. (81) 2017 Shahrekord Case: 50
Control: 77
All c In: Case 90%, control 82%
Alle t In: Case 10% control 16.2%
Sazgar H. (82) 2017 Shahrekord Case: 100
Control: 100
CT genotype OR(CI): 3.59(2.04–6.69)